1. Tomalia A., Baker H., Dewald J., Hall M., Kallos G., Martin S., Roeck J., Ryder J and Smith PA New Class of Polymers: Starburst-Dendriticmacromolecules. Polym. J, 1985, 17, 117-132.
2. Singhai, A.K., Jain, S., Jain, N.K., Evaluation of an aqueous ketopofen. Pharmazie, 1995, 52, 214-1251.
3. Sakthivel.T and Florence A.T., Adsorption of Amphipathic Dendrons on Polystyrene nanoparticles. Int. J. Pharm, 2003, 254, 23-26.
4. Hawker, C., Wooley, K.L and Frechet J.M.J., J. Chem. Soc. Perkin. Tran.1. 1993,
1287-1289.
5. Hawker.C., Frechet, J.M.J., 1990.A new convergent approach to monodisperse dendritic molecule. J. Chem Soc. Chem.
Commun, 1990, 15, 1010-1012.
6. Barbara,K.,Maria,B.ReviewDendrimers:P ropertiesandapplications.ActaBiochimica,20
01,48,199-208 .
7. Lee, C.C., MacKay, J.M., Szoka, F.C., Designing dendrimers for biological
ISSN: 2277-8713
IJPRBS
applications.Nat.Biotechol, 2005, 23, 1517¬1526.
8. Wang,D.J.,Imae.T., fluorescence emission from dendrimers and its pH dependence.J.Am.Chem.Soc,2004,126,1320 4-13205.
9. Newkome, G.R., Yao, Z.Q., Baker, G.R and Gupta, V.K., Cascade molecules: A new approach to micelles.Org.Chem.1985, 50, 2003-2006.
10. Pushkar, S., Philip, A., Pathak.K and Pathak.D., Dendrimers: Nanotechnology Derived Novel Polymers in Drug Delivery. Indian J. Pharm. Educ. Res, 2006, 40, 53¬158.
11. Yang, H., Kao, W.J., Dendrimers for pharmaceutical and biomedical applications.Biomater.sci.polym, 2006, 17,
3-19.
12. Svenson, S., Tomali, D.A.,.Dendrmers in biomedical applications-reflections
Rev.Drug.Rev,2005,57, 2106-2129.
13. Bhadra, D., Bhadra, S., Jain, P., Pegenology: a review of PEGylated systems.Pharmazi, 2002, 57, 5-29.
14. Khan M.K., Nigavekar S.S., Minc L.D. , Kariapper M.S., Nair B.M., Lesniak W.G., Balogh L.P., In vitro distribution of dendrimers and dendrimer nano composites-implications for cancer imaging and therapy. Technol. Cancer Res. Treat,
2005, 4, 603-601.
Available Online at www.ijprbs.com
Review Article CODEN: IJPRNK
Navya Davuluri, IJPRBS, 2013; Volume 2(4): 346-371
15. Cho, B.K., Roy, E.J., Patrick, T.A., Kranz, D.M., Single-chain Fv/folate conjugates mediate efficient lysis of folate receptor-positive tumor cells. Bioconjug. Chem,
1997, 8, 338-346.
16. Roberts, J.C., Bhalgat, M.K., Zera, R.T., Preliminary biological evaluation of polyamidoamine (PAMAM) starburst dendrimers. J. Biomed. Mater. Res, 1996,
30, 53-65.
17. Yiyun, C., Zhenhua, X., Minglu. M and Tonguen.X., Dendrimers as Drug Carriers: Applications in Different Routes of Drug.J.Pharma.Sci,2008,97, 123-143.
18. Bhadra D., Bhadra S., Jain S., Jain N.K., A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm, 257, 111-124.
19. Brigger, I., Dubernet, C., Couvreur, P., Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev, 2001, 54, 631.
20. Brannon-Peppas, L., Blanchette, J.O., Nanoparticle and targeted systems for
ISSN: 2277-8713 IJPRBS
cancer therapy, Adv. Drug Deliv. Rev, 2004,
56, 1649-1659.
21. Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., Corti, A., Enhancement of factor alpha anti-tumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).Nat. Biotechnol,2000,18, 1185-1190
22. Amantea, M.A., Forrest A., Northfelt D.W., Mamelok R., Population pharmacokinetics and pharmacodynamics of PEGylated-liposomal doxorubicin in patients with AIDS related aposi's sarcoma. Clin Pharmacol Therap, 1997, 61, 301-31.
23. Curnis, F., Sacchi, A., Corti, A., Improving chemotherapeutic drug penetration in tumours by vascular targeting and barrier
alteration. J. Clin. Invest, 2002, 18, 475-482.
24. Gillies, E.R., Frechet, J.M., Dendrimer and drug polymers in drug delivery. Drug Discov. Today, 2005, 10, 35-43.
Thank you for copying data from http://www.arastirmax.com
